Prelude Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.24M Buy
15,000
+986
+7% +$81.8K 0.12% 210
2025
Q1
$1.14M Buy
+14,014
New +$1.14M 0.09% 227
2024
Q4
Sell
-4,130
Closed -$408K 1475
2024
Q3
$408K Buy
+4,130
New +$408K 0.02% 632
2024
Q1
Sell
-3,440
Closed -$307K 1436
2023
Q4
$307K Buy
3,440
+294
+9% +$26.3K 0.02% 625
2023
Q3
$230K Buy
+3,146
New +$230K 0.02% 693
2022
Q4
Hold
0
1526
2022
Q3
Hold
0
1808
2022
Q2
Hold
0
1860
2022
Q1
Hold
0
1972
2021
Q4
Hold
0
1966
2021
Q3
Sell
-9,797
Closed -$1.33M 1755
2021
Q2
$1.33M Buy
+9,797
New +$1.33M 0.04% 353
2021
Q1
Hold
0
1427
2020
Q4
Hold
0
1622
2020
Q3
Hold
0
1908
2020
Q2
Hold
0
1748
2020
Q1
Hold
0
1630
2019
Q4
Hold
0
1812
2019
Q3
Hold
0
1634
2019
Q2
Hold
0
1768
2019
Q1
Hold
0
1798
2018
Q4
Hold
0
1786
2018
Q3
Hold
0
1716
2018
Q2
Hold
0
1695
2018
Q1
Hold
0
1585
2017
Q4
Hold
0
1616
2017
Q3
Hold
0
1808
2017
Q2
Hold
0
1799
2016
Q1
Hold
0
1480
2015
Q4
Hold
0
1629
2015
Q2
Sell
-6,300
Closed -$474K 1986
2015
Q1
$474K Buy
+6,300
New +$474K 0.07% 346